Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × Fatigue × Methylphenidate × Clear all

Phase

Phase 3 5 Phase 2 4 Phase 2/3 3 Phase 1 2

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Fatigue 2 Neoplasms 1

Interventions

Methylphenidate 2 coenzyme Q10 1 Vitamin E 1 Surveys and Questionnaires 1 Sodium Chloride 1 Sildenafil Citrate 1 Ritonavir 1 Quality of Life 1 Metformin 1 5,10-dihydro-5-methylphenazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02361125 2022-01-04

Patient Controlled Administration of Methylphenidate for Cancer Related Fatigue - PRN Methylphenidate

M.D. Anderson Cancer Center

Phase 1 Completed

Fatigue

NCT01164956 2019-04-26

Methylphenidate for Cancer-Related Fatigue

Dana-Farber Cancer Institute

Phase 1 Terminated

3 enrolled 7 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡